Chemoinformaics analysis of P-Mentha-1,8-Dien-10-Al
| Molecular Weight | 150.221 | nRot | 2 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 8 |
| Exact Molecular Weight | 150.104 | nRing | 1 |
| Solubility: LogS | -2.819 | nHRing | 0 |
| Solubility: LogP | 2.817 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 26.8371 |
| nHD | 0 | BPOL | 14.9129 |
| QED | 0.336 |
| Synth | 3.748 |
| Natural Product Likeliness | 2.868 |
| NR-PPAR-gamma | 0.25 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.014 |
| CACO-2 | -4.397 |
| MDCK | 0.0000212 |
| BBB | 0.996 |
| PPB | 0.761152 |
| VDSS | 2.33 |
| FU | 0.143058 |
| CYP1A2-inh | 0.613 |
| CYP1A2-sub | 0.126 |
| CYP2c19-inh | 0.297 |
| CYP2c19-sub | 0.459 |
| CYP2c9-inh | 0.068 |
| CYP2c9-sub | 0.806 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.666 |
| CYP3a4-inh | 0.036 |
| CYP3a4-sub | 0.244 |
| CL | 6.449 |
| T12 | 0.555 |
| hERG | 0.003 |
| Ames | 0.68 |
| ROA | 0.083 |
| SkinSen | 0.892 |
| Carcinogencity | 0.953 |
| EI | 0.972 |
| Respiratory | 0.978 |
| NR-Aromatase | 0.147 |
| Antiviral | No |
| Prediction | 0.943663 |